NEW YORK (GenomeWeb News) – Investigators at Hartford Hospital's Genetics Research Center and Institute of Living will use a nearly $1.3 million federal grant to study the use of pharmacogenomic approaches in choosing medications for psychiatric patients.

The GRC and IOL researchers plan to use the funds from the Agency for Healthcare Research and Quality to find out whether the use of genetic testing to select medications affects psychiatric patients' length of stay in the hospital or their readmission rates, Hartford Hospital said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.